{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:24:16Z","timestamp":1782221056264,"version":"3.54.5"},"reference-count":70,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["31652-18-024-01-CPPB"],"award-info":[{"award-number":["31652-18-024-01-CPPB"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Tumor genomic profiling (TGP) is used in oncology practice to optimize cancer treatment and improve survival rates. However, TGP is underutilized among Black and African American (AA) patients, creating potential disparities in cancer treatment outcomes. Cost, accuracy, and privacy are barriers to genetic testing, but medical mistrust (MM) may also influence how Black and AA cancer patients perceive TGP. From December 2019 to February 2020, 112 Black and AA adults from two outpatient oncology sites in Philadelphia, PA without a known history of having TGP testing conducted completed a cross-sectional survey. Items queried included sociodemographic characteristics, clinical factors, patient\u2013oncologist relationship quality, medical mistrust, and concerns about TGP. A k-means cluster analysis revealed two distinct psychographic clusters: high (MM-H) versus low (MM-L) medical mistrust. Clusters were not associated with any sociodemographic or clinical factors, except for age (MM-H patients older than MM-L patients, p = 0.006). Eleven TGP concerns were assessed; MM-H patients expressed greater concerns than MM-L patients, including distrust of the government, insurance carriers, and pharmaceutical companies. TGP concerns varied significantly based on level of medical mistrust, irrespective of sociodemographic characteristics. Targeted communications addressing TGP concerns may mitigate disparities in TGP uptake among those with medical mistrust.<\/jats:p>","DOI":"10.3390\/ijerph19052598","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T22:54:02Z","timestamp":1645656842000},"page":"2598","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Role of Medical Mistrust in Concerns about Tumor Genomic Profiling among Black and African American Cancer Patients"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1360-0358","authenticated-orcid":false,"given":"Ariel","family":"Hoadley","sequence":"first","affiliation":[{"name":"Risk Communication Laboratory, Department of Social and Behavioral Sciences, College of Public Health, Temple University, 1301 Cecil B Moore Ave, Rm 947, Philadelphia, PA 19122, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Bauerle","family":"Bass","sequence":"additional","affiliation":[{"name":"Risk Communication Laboratory, Department of Social and Behavioral Sciences, College of Public Health, Temple University, 1301 Cecil B Moore Ave, Rm 947, Philadelphia, PA 19122, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Chertock","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center, Cancer Prevention and Control Program, Department of Clinical Genetics, 333 Cottman Avenue, Philadelphia, PA 19111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Brajuha","sequence":"additional","affiliation":[{"name":"Risk Communication Laboratory, Department of Social and Behavioral Sciences, College of Public Health, Temple University, 1301 Cecil B Moore Ave, Rm 947, Philadelphia, PA 19122, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3007-0099","authenticated-orcid":false,"given":"Paul","family":"D\u2019Avanzo","sequence":"additional","affiliation":[{"name":"Risk Communication Laboratory, Department of Social and Behavioral Sciences, College of Public Health, Temple University, 1301 Cecil B Moore Ave, Rm 947, Philadelphia, PA 19122, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1462-1150","authenticated-orcid":false,"given":"Patrick J.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Risk Communication Laboratory, Department of Social and Behavioral Sciences, College of Public Health, Temple University, 1301 Cecil B Moore Ave, Rm 947, Philadelphia, PA 19122, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Hall","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center, Cancer Prevention and Control Program, Department of Clinical Genetics, 333 Cottman Avenue, Philadelphia, PA 19111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1200\/JOP.19.00201","article-title":"When should tumor genomic profiling prompt consideration of germline testing?","volume":"15","author":"DeLeonardis","year":"2019","journal-title":"J. Oncol. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00283","article-title":"Prospective comprehensive genomic profiling of primary and metastatic prostate tumors","volume":"3","author":"Chung","year":"2019","journal-title":"JCO Precis. Oncol."},{"key":"ref_3","first-page":"525","article-title":"Assessment of clinical benefit of integrative genomic profiling in advanced solid tumors","volume":"7","author":"Cobain","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(20)30074-7","article-title":"Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: A retrospective analysis of the Know Your Tumor registry trial","volume":"21","author":"Pishvaian","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jamaoncol.2016.2129","article-title":"Association of Biomarker-Based Treatment Strategies with Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms","volume":"2","author":"Schwaederle","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/2159-8290.CD-19-0442","article-title":"Tumor genomic profiling guides patients with metastatic gastric cancer to targeted treatment: The VIKTORY Umbrella Trial","volume":"9","author":"Lee","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41587-019-0259-z","article-title":"Integrated genomic profiling expands clinical options for patients with cancer","volume":"37","author":"Beaubier","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1200\/JOP.18.00661","article-title":"Implementing Precision Medicine in Community-Based Oncology Programs: Three Models","volume":"15","author":"Levit","year":"2019","journal-title":"J. Oncol. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1377\/hlthaff.2017.1575","article-title":"Strategies For Clinical Implementation: Precision Oncology at Three Distinct Institutions","volume":"37","author":"Nadauld","year":"2018","journal-title":"Health Aff."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.drudis.2015.08.005","article-title":"Precision medicine at Memorial Sloan Kettering Cancer Center: Clinical next-generation sequencing enabling next-generation targeted therapy trials","volume":"20","author":"Hyman","year":"2015","journal-title":"Drug Discov. Today"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41591-019-0380-z","article-title":"Utility of ctDNA to support patient selection for early phase clinical trials: The TARGET study","volume":"25","author":"Rothwell","year":"2019","journal-title":"Nat. Med."},{"key":"ref_13","first-page":"620","article-title":"Oncologist Confidence in Genomic Testing and Implications for Using Multimarker Tumor Panel Tests in Practice","volume":"4","author":"Gray","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10549-020-05557-x","article-title":"Trend and survival benefit of Oncotype DX use among female hormone receptor-positive breast cancer patients in 17 SEER registries, 2004\u20132015","volume":"180","author":"Zhang","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature.2015.16774","article-title":"PUS precision-medicine plan raises hopes: US initiative highlights growing focus on targeted therapies","volume":"517","author":"Reardon","year":"2015","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"653805","DOI":"10.1155\/2013\/653805","article-title":"Utilization of Oncotype DX in an Inner City Population: Race or Place?","volume":"2013","author":"Guth","year":"2013","journal-title":"Int. J. Breast Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMc2000069","article-title":"Racial Differences in Genomic Profiling of Prostate Cancer","volume":"383","author":"Mahal","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/cncr.29951","article-title":"Patient preferences regarding incidental genomic findings discovered during tumor profiling","volume":"122","author":"Yushak","year":"2016","journal-title":"Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/cncr.24248","article-title":"Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer","volume":"115","author":"Hardy","year":"2009","journal-title":"Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/1055-9965.EPI-18-0917","article-title":"Disparities and Trends in Genetic Testing and Erlotinib Treatment among Metastatic Non\u2013Small Cell Lung Cancer Patients","volume":"28","author":"Palazzo","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/COC.0000000000000875","article-title":"Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer","volume":"44","author":"Punekar","year":"2021","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lynch, J.A., Berse, B., Rabb, M., Mosquin, P., Chew, R., West, S.L., Coomer, N., Becker, D., and Kautter, J. (2018). Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010\u20132013. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4190-3"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ajog.2017.09.016","article-title":"Endometrial cancer disparities: A race-conscious critique of the literature","volume":"218","author":"Doll","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Anderson, E.C., Hinton, A.C., Lary, C.W., Fenton, A.T., Antov, A., Edelman, E., Helbig, P., Reed, K., Miesfeldt, S., and Thomas, C.A. (2021). Community oncologists\u2019 perceptions and utilization of large-panel genomic tumor testing. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08985-0"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Best, M.C., Bartley, N., Jacobs, C., Juraskova, I., Goldstein, D., Newson, A.J., Savard, J., Meiser, B., Napier, C., and Thomas, D. (2019). Patient perspectives on molecular tumor profiling: \u201cWhy wouldn\u2019t you?. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5920-x"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/virtualmentor.2013.15.8.stas1-1308","article-title":"The Promise and Pitfalls of Genomics-Driven Cancer Medicine","volume":"15","author":"Hofstatter","year":"2013","journal-title":"AMA J. Ethics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.6004\/jnccn.2016.0080","article-title":"The Relevance of Hereditary Cancer Risks to Precision Oncology: What Should Providers Consider When Conducting Tumor Genomic Profiling?","volume":"14","author":"Jain","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1002\/cncr.28807","article-title":"Genomic testing in cancer: Patient knowledge, attitudes, and expectations","volume":"120","author":"Blanchette","year":"2014","journal-title":"Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hann, K.E., Freeman, M., Fraser, L., Waller, J., Sanderson, S.C., Rahman, B., and Lanceley, A. (2017). Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: A systematic review. BMC Public Health, 17.","DOI":"10.1186\/s12889-017-4375-8"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.pec.2015.12.020","article-title":"Racial disparities in patient activation: Evaluating the mediating role of health literacy with path analyses","volume":"99","author":"Gwynn","year":"2016","journal-title":"Patient Educ. Couns."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/10810730.2014.943377","article-title":"Measurement of Cancer Health Literacy and Identification of Patients with Limited Cancer Health Literacy","volume":"19","author":"Dumenci","year":"2014","journal-title":"J. Health Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.amepre.2009.07.021","article-title":"Racial and ethnic disparities in awareness of genetic testing for cancer risk","volume":"37","author":"Su","year":"2009","journal-title":"Am. J. Prev. Med."},{"key":"ref_34","first-page":"e171","article-title":"Are Health Literacy and Patient Activation Related to Health Outcomes in Breast Cancer Patients?","volume":"5","author":"Kanu","year":"2021","journal-title":"HLRP Health Lit. Res. Pract."},{"key":"ref_35","first-page":"e138","article-title":"Health literacy in African-American communities: Barriers and strategies","volume":"4","author":"Muvuka","year":"2020","journal-title":"HLRP Health Lit. Res. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1080\/10810730.2015.1018638","article-title":"Health Literacy and Health-Related Quality of Life among a Population-Based Sample of Cancer Patients","volume":"20","author":"Halverson","year":"2015","journal-title":"J. Health Commun."},{"key":"ref_37","first-page":"e153","article-title":"Health literacy is an independent predictor of cancer patients\u2019 hospitalizations","volume":"1","author":"Cartwright","year":"2017","journal-title":"HLRP Health Lit. Res. Pract."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000517486","article-title":"Oncologists\u2019 Perceptions of Tumor Genomic Profiling and the Communication of Test Results and Risks","volume":"24","author":"Hall","year":"2021","journal-title":"Public Health Genom."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hast.1240","article-title":"Antiracist Praxis in Public Health: A Call for Ethical Reflections","volume":"51","author":"Fletcher","year":"2021","journal-title":"Hast. Cent. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10464-009-9280-6","article-title":"Psychosocial Correlates of Medical Mistrust among African American Men","volume":"45","author":"Hammond","year":"2010","journal-title":"Am. J. Community Psychol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"108551","DOI":"10.1016\/j.jsat.2021.108551","article-title":"Experiences of racial discrimination in the medical setting and associations with medical mistrust and expectations of care among black patients seeking addiction treatment","volume":"133","author":"Hall","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"key":"ref_42","first-page":"630","article-title":"Why African Americans may not be participating in clinical trials","volume":"88","author":"Harris","year":"1996","journal-title":"J. Natl. Med. Assoc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1200\/JCO.1999.17.3.1029","article-title":"Recruiting Minority Cancer Patients Into Cancer Clinical Trials: A Pilot Project Involving the Eastern Cooperative Oncology Group and the National Medical Association","volume":"17","author":"Pinto","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaoncol.2020.8482","article-title":"Redefining attribution from patient to health system\u2014How the notion of \u201cmistrust\u201d places blame on Black patients","volume":"7","author":"Borno","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.amepre.2018.05.028","article-title":"Attitudes Toward Genomic Testing and Prostate Cancer Research among Black Men","volume":"55","author":"Rogers","year":"2018","journal-title":"Am. J. Prev. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.1200\/JOP.2016.020057","article-title":"Interest and Attitudes of Patients With Advanced Cancer with Regard to Secondary Germline Findings From Tumor Genomic Profiling","volume":"13","author":"Hamilton","year":"2017","journal-title":"J. Oncol. Pract."},{"key":"ref_47","unstructured":"Bass, S.B., Chertock, Y., Brajuha, J., and Hall, M. (2019, January 2\u20136). Perceptions of tumor genomic profiling in African American cancer patients: An in-depth qualitative analysis. Proceedings of the APHA\u2019s 2019 Annual Meeting and Expo, Philadelphia, PA, USA."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ypmed.2003.09.041","article-title":"The Group-Based Medical Mistrust Scale: Psychometric properties and association with breast cancer screening","volume":"38","author":"Thompson","year":"2004","journal-title":"Prev. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2147\/JMDH.S107851","article-title":"Patient-centeredness and empathy in a bilingual interprofessional primary care teaching clinic: A pilot study","volume":"9","author":"Mayer","year":"2016","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Everitt, B.S., Landau, S., Leese, M., and Stahl, D. (2011). Cluster Analysis, John Wiley & Sons, Inc.. [5th ed.].","DOI":"10.1002\/9780470977811"},{"key":"ref_51","first-page":"17","article-title":"Medical Mistrust Influences Black Women\u2019s Level of Engagement in BRCA1\/2 Genetic Counseling and Testing","volume":"105","author":"Sheppard","year":"2013","journal-title":"J. Natl. Med. Assoc."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Callaghan, T., Haeder, S.F., and Sylvester, S. (2021). Past Experiences with Surprise Medical Bills Drive Issue Knowledge, Concern and Attitudes toward Federal Policy Intervention. Health Economics, Policy and Law, Cambridge University Press.","DOI":"10.1017\/S1744133121000281"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.2020.26779","article-title":"Surprise billing\u2014A flashpoint for major policy issues in health care","volume":"325","author":"Colla","year":"2021","journal-title":"JAMA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1111\/j.1524-4741.2009.00798.x","article-title":"Influence of Race\/Ethnicity on Genetic Counseling and Testing for Hereditary Breast and Ovarian Cancer","volume":"15","author":"Forman","year":"2009","journal-title":"Breast J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIRCULATIONAHA.120.049207","article-title":"Surprise medical billing: Compelling need to address uncertainty, anxiety, and financial peril for patients","volume":"142","author":"Churchwell","year":"2020","journal-title":"Circulation"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1200\/JOP.2015.004408","article-title":"Cost-Related Health Literacy: A Key Component of High-Quality Cancer Care","volume":"11","author":"Zafar","year":"2015","journal-title":"J. Oncol. Pract."},{"key":"ref_57","unstructured":"Centers for Medicare & Medicaid Services (2022, January 18). National Coverage Determination (NCD) for Next Generation Sequencing (NGS) (90.2), Available online: https:\/\/www.cms.gov\/medicare-coverage-database\/view\/ncd.aspx?NCDId=372."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1001\/jama.2018.4863","article-title":"Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the end or end of the beginning?","volume":"319","author":"Phillips","year":"2018","journal-title":"JAMA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e2138219","DOI":"10.1001\/jamanetworkopen.2021.38219","article-title":"Trends in Use of Next-Generation Sequencing in Patients with Solid Tumors by Race and Ethnicity after Implementation of the Medicare National Coverage Determination","volume":"4","author":"Sheinson","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S0963180100005168","article-title":"African American Suspicion of the Healthcare System Is Justified: What Do We Do about It?","volume":"3","author":"Dula","year":"1994","journal-title":"Camb. Q. Healthc. Ethics"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2105\/AJPH.2019.305243","article-title":"Black Maternal and Infant Health: Historical Legacies of Slavery","volume":"10","author":"Owens","year":"2019","journal-title":"Am. J. Public Health"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1353\/hpu.2020.0012","article-title":"Sociodemographic Correlates of Medical Mistrust among African American Men Living in the East Bay","volume":"31","author":"Idan","year":"2020","journal-title":"J. Health Care Poor Underserved"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1370\/afm.2632","article-title":"Discrimination and medical mistrust in a racially and ethnically diverse sample of California adults","volume":"19","author":"Bazargan","year":"2021","journal-title":"Ann. Fam. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amepre.2020.08.019","article-title":"Using Mistrust, Distrust, and Low Trust Precisely in Medical Care and Medical Research Advances Health Equity","volume":"60","author":"Griffith","year":"2021","journal-title":"Am. J. Prev. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/08964289.2019.1619511","article-title":"Towards a More Inclusive and Dynamic Understanding of Medical Mistrust Informed by Science","volume":"45","author":"Jaiswal","year":"2019","journal-title":"Behav. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1155\/2014\/470261","article-title":"From the mouth of babes: Getting vaccinated doesn\u2019t have to hurt","volume":"25","author":"Taddio","year":"2014","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1037\/hea0000721","article-title":"Can patient-centered communication reduce the effects of medical mistrust on patients\u2019 decision making?","volume":"38","author":"Cuevas","year":"2019","journal-title":"Health Psychol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1177\/1557988318786669","article-title":"Choosing Channels, Sources, and Content for Communicating Prostate Cancer Information to Black Men: A Systematic Review of the Literature","volume":"12","author":"Odedina","year":"2018","journal-title":"Am. J. Men\u2019s Health"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejmg.2018.12.004","article-title":"Effective communication in the era of precision medicine: A pilot intervention with low health literacy patients to improve genetic counseling communication","volume":"62","author":"Joseph","year":"2019","journal-title":"Eur. J. Med. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10689-020-00176-3","article-title":"Systematic development of a training program for healthcare professionals to improve communication about breast cancer genetic counseling with low health literate patients","volume":"19","author":"Ausems","year":"2020","journal-title":"Fam. Cancer"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/5\/2598\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:25:42Z","timestamp":1760135142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/5\/2598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":70,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["ijerph19052598"],"URL":"https:\/\/doi.org\/10.3390\/ijerph19052598","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]}}}